Hisamitsu Pharmaceutical Competitors and Similar CompaniesClear all
Hisamitsu Pharmaceutical's competitors and similar companies include Luye Pharma, Livzon Pharmaceutical Group, Jiangsu Hansoh Pharmaceutical Group and Nipro.
 Hisamitsu Pharmaceutical Hisamitsu Pharmaceutical (久光製藥株式會社) is a company manufacturing external analgesic and anti-inflammatory preparations, such as medicated plasters, gels, sprays, etc. |  Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. | ||
Founding Date | Founding Date 1847 | Founding Date 1994 | Founding Date 1985 | Founding Date 1995 | Founding Date 1954 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations CN HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Lianyungang Shi, CN HQ | ||
Employees | Employees 2,759 | Employees 5,150 | Employees 9,067 | Employees 8,989 | Employees 38,117 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) 1.5 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥163b (FY, 2026) | Revenue (est.) ¥6.3b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ¥15b (FY, 2025) | Revenue (est.) ¥660.5b (FY, 2026) |
Cost of goods | Cost of goods ¥59.9b (FY, 2026) | Cost of goods ¥1.3b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ¥1.1b (FY, 2025) | Cost of goods ¥388.5b (FY, 2026) |
Gross profit | Gross profit ¥103.2b (FY, 2026) | Gross profit ¥5.1b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit ¥14b (FY, 2025) | Gross profit ¥272b (FY, 2026) |
Net income | Net income ¥19.6b (FY, 2026) | Net income ¥705.7m (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income ¥5.6b (FY, 2025) | Net income ¥15.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Luye Pharma
HQ
CN
Employees
5,150
Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company
Jiangsu Hansoh Pharmaceutical Group
HQ
Lianyungang Shi, CN
Employees
8,989
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
View companyNipro
HQ
Settsu, JP
Employees
38,117
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.
View company